Insiders / Falcon Edge Capital LP
Falcon Edge Capital LP
CIK 1558858institutionfundinsiderbeneficial owner
Companies
6
First seen
Feb 17, 2015
Last activity
Aug 13, 2026
Holdings
6 companies · 4 positionsView all →
| Company / security | Shares held | Latest |
|---|---|---|
| Pioneer Merger Corp. · PACX | 4,450,000 | — |
| Class A ordinary shares | 4,450,000 | Jan 12, 2021 |
| Alto Neuroscience, Inc. · ANRO | 3,707,757 | — |
| Common stock | 3,707,757 | Feb 6, 2024 |
| Frontier Acquisition Corp. · FRONU | 2,400,000 | — |
| Class A ordinary shares | 2,400,000 | Mar 15, 2021 |
| Golden Falcon Acquisition Corp. · GFX | 750,000 | — |
| Class A common stock | 750,000 | Dec 27, 2022 |
| Apnimed, Inc. · APMD | — | — |
| Graphite Bio, Inc. · GRPH | — | — |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 6, 2024 | Buy Open-market buy | ANRO Alto Neuroscience, Inc. Common Stock | $9.60M | +600K +19.31% | 3,707,757 9.45% of shares | high |
| Feb 6, 2024 | Other Derivative conversion | ANRO Alto Neuroscience, Inc. Series C Convertible Preferred Stock (Series C Preferred) | — | -1.1M -100.00% | 0 0.00% of shares | low |
| Feb 6, 2024 | Other Derivative conversion | ANRO Alto Neuroscience, Inc. |